TD Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-35,920
| Closed | -$745K | – | 1485 |
|
|
2021
Q4 | $745K | Buy |
35,920
+5,410
| +18% | +$112K | ﹤0.01% | 1330 |
|
|
2021
Q3 | $729K | Hold |
30,510
| – | – | ﹤0.01% | 1321 |
|
|
2021
Q2 | $712K | Sell |
30,510
-3,145
| -9% | -$73.4K | ﹤0.01% | 1334 |
|
|
2021
Q1 | $974K | Buy |
33,655
+25,100
| +293% | +$726K | ﹤0.01% | 1265 |
|
|
2020
Q4 | $241K | Sell |
8,555
-11,919
| -58% | -$336K | ﹤0.01% | 1410 |
|
|
2020
Q3 | $600K | Hold |
20,474
| – | – | ﹤0.01% | 1198 |
|
|
2020
Q2 | $619K | Hold |
20,474
| – | – | ﹤0.01% | 1172 |
|
|
2020
Q1 | $610K | Buy |
+20,474
| New | +$610K | ﹤0.01% | 1123 |
|